Central nervous system distribution of buprenorphine in pregnant sheep, fetuses and newborn lambs after continuous transdermal and single subcutaneous extended-release dosing-Reference-Cited by-同舟云学术

Central nervous system distribution of buprenorphine in pregnant sheep, fetuses and newborn lambs after continuous transdermal and single subcutaneous extended-release dosing

Published:2022-11 Issue: Volume:178 Page:106283
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Hakomäki Henriikka^ORCID,Eskola Sophia,Kokki Hannu,Lehtonen Marko,Räsänen Juha,Laaksonen Sakari,Voipio Hanna-Marja,Ranta Veli-Pekka,Kokki Merja

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. Opioid use and opioid use disorder in pregnancy;Committee Opinion, Number,2017

2. Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade: An Open-Label Phase 1 Study;Albayata;Adv. Ther.,2017

3. Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo;Auvity;Neuropsychopharmacology,2021

4. Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor;Bloms-Funke;Peptides,2000

5. P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception;Brown;J. Pharmacol. Exp. Ther.,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma concentrations of buprenorphine administered via matrix-type transdermal patches applied at three different anatomical locations in healthy adult horses;Frontiers in Pain Research;2024-06-19

2. Evaluation of physical variables, thermal nociceptive threshold testing and pharmacokinetics during placement of transdermal buprenorphine matrix-type patch in healthy adult horses;Frontiers in Pain Research;2024-03-11

3. Buprenorphine for Chronic Pain Management: a Narrative Review;Current Pain and Headache Reports;2023-10-28

4. Buprenorphine plasma and cerebrospinal fluid concentrations in osteoarthritis patients during low-dose transdermal patch dosing;European Journal of Clinical Pharmacology;2023-10-21